Orkambi, a New Cystic Fibrosis Drug, Wins F.D.A. Approval

Friday, July 3, 2015 - 06:00 in Health & Medicine

The drug is the second one brought to market by Vertex and could be effective for more patients than the first drug, Kalydeco.

Read the whole article on NY Times Health

More from NY Times Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net